Results 11 to 20 of about 10,023 (255)

AVALIAÇÃO DA RESPOSTA DO CARCINOMA HEPATOCELULAR À QUIMIOEMBOLIZAÇÃO ATRAVÉS DO EXPLANTE

Brazilian Journal of Transplantation, 2012
Introdução: O transplante hepático é empregado no tratamento do carcinoma hepatocelular em pacientes cirróticos que se enquadram nos Critérios de Milão com resultados adequados.
Yuri Longatto , Amanda Pinter Carvalheiro da Silva, Elaine Cristina Ataide, Plinio Turine Neto, Ilka de Fátima Ferreira Boin   +4 more
doaj   +3 more sources

Lobectomia hepática parcial em cadela da raça Border Collie diagnosticada com carcinoma hepatocelular

Pubvet
O carcinoma hepatocelular é a neoplasia hepática de maior incidência em cães, e a forma maciça que consiste em acometer apenas um lobo, representa 50% dos acometimentos entre a forma nodular e difusa do CHC.
Francisco de Assis de Oliveira Souza, Safira Helene Ferreira Miranda, Rychel Teixeira Pereira Pereira, Roberto Carlos Bulamarque Sousa Sousa, Gabriel Albuquerque Serrão Serrão, Luna Almeida da Silva Reginato Rodrigues Rodrigues, Rebeca Belém Paredes Paredes, Bruno de Cássio Veloso de Barros   +7 more
doaj   +3 more sources

Hipercalcemia como complicación de hepatocarcinoma

Revista Methodo, 2022
El carcinoma hepatocelular es el tumor hepático maligno más frecuente. El mismo puede producir, raramente, metástasis óseas líticas o síndromes paraneoplásicos que generan hipercalcemia, disminuyendo la probabilidad de supervivencia de los pacientes.
Bertello M, Lucero P
doaj   +1 more source

Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?

Journal of Viral Hepatitis, Volume 30, Issue 10, Page 790-792, October 2023., 2023
Abstract Hepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma and mortality among people living with HIV (PLWH). HBV vaccination provides protection from infection; however, vaccination rates are low. We conducted a retrospective analysis at three HIV centres in Texas to determine the proportion of PLWH who ...
Angie Garcia, Karen J. Vigil, Barbara Taylor, Onkar Kshirsagar, Mae Thamer, Mamta K. Jain   +5 more
wiley   +1 more source

Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics

Advanced Healthcare Materials, Volume 10, Issue 16, August 18, 2021., 2021
Selenium has anti‐inflammatory, immunomodulatory and antioxidant properties, and its application in nanotechnology improves its therapeutic properties, while decreasing the potential toxicity. Selenium nanoparticles have medicinal applications against diabetes, Alzheimer's disease, inflammatory and autoimmune diseases, microbial infections, and several
Cláudio Ferro, Helena F. Florindo, Hélder A. Santos   +2 more
wiley   +1 more source

Carcinoma hepatocelular. Parte 1: considerações gerais e diagnóstico [PDF]

Arquivos de Gastroenterologia, 2000
São revistos aspectos relativos à incidência/prevalência, fatores de risco, proliferação celular (carcinogênese), anatomia patológica, progressão e evolução das hepatites virais B e C para o carcinoma hepatocelular inicial, alguns dados clínicos da ...
Vinício Paride CONTE
doaj   +1 more source

Carcinoma hepatocelular. Diagnóstico diferencial

RECIAMUC, 2021
El carcinoma hepatocelular o hepatocarcinoma es la neoplasia primaria hepática maligna más común a nivel mundial. Por lo general se desarrolla en pacientes con enfermedad hepática crónica que han desarrollado una cirrosis de cualquier etiología, más es particularmente asociada con a con infección por los virus de la hepatitis B y C (VHB y VHC).
Karla Abigail Navarrete Bolaños, Jessica Cristina Andrade Villarreal, Daysi Maricela Jacho Oña, Jenifer Lizbeth Calapaqui Araque   +3 more
openaire   +4 more sources

Volume–outcome relationship of liver surgery: a nationwide analysis

BJS (British Journal of Surgery), Volume 107, Issue 7, Page 917-926, June 2020., 2020
This study analysed the association between hospital volume and postoperative outcomes in the nationwide Dutch Hepato Biliary Audit. A total of 5590 resections was performed across 34 centres with a median annual centre volume of 35 (i.q.r. 20–69) procedures. No association was found between hospital and postoperative outcomes.
P. B. Olthof, A. K. E. Elfrink, E. Marra, E. J. T. Belt, P. B. van den Boezem, K. Bosscha, E. C. J. Consten, M. den Dulk, P. D. Gobardhan, J. Hagendoorn, T. N. T. van Heek, J. N. M. IJzermans, J. M. Klaase, K. F. D. Kuhlmann, W. K. G. Leclercq, M. S. L. Liem, E. R. Manusama, H. A. Marsman, J. S. D. Mieog, S. J. Oosterling, G. A. Patijn, W. te Riele, R.‐J. Swijnenburg, H. Torrenga, P. van Duijvendijk, M. Vermaas, N. F. M. Kok, D. J. Grünhagen, Dutch Hepato Biliary Audit Group, M. G. H. Besselink, M. T. de Boer, C. I. Buis, T. M. van Gulik, F. J. H. Hoogwater, I. Q. Molenaar, C. H. C. Dejong, C. Verhoef   +36 more
wiley   +1 more source

Liver resection with thrombectomy for patients with hepatocellular carcinoma and tumour thrombus in the inferior vena cava or right atrium

BJS Open, Volume 4, Issue 2, Page 241-251, April 2020., 2020
Hepatocellular carcinoma with tumour thrombus in the inferior vena cava or right atrium is an advanced disease state with a poor prognosis. This retrospective study examined the survival benefits of surgical resection for patients with this rare condition.
S. Matsukuma, H. Eguchi, H. Wada, T. Noda, Y. Shindo, Y. Tokumitsu, H. Matsui, H. Takahashi, S. Kobayashi, H. Nagano   +9 more
wiley   +1 more source

Upper Gastrointestinal Hemorrhage as an Unexpected Feature of Hepatocellular Carcinoma [PDF]

GE: Portuguese Journal of Gastroenterology, 2015
Rosa Coelho, Branca Orfão, João Santos-Antunes, Eduardo Rodrigues-Pinto, Pedro Pereira, Helena Baldaia, Guilherme Macedo   +6 more
doaj   +2 more sources